Area of research
Hematology · Oncology
Research interest
Research focused on Multiple myeloma and Cancer research, with related work in RUNX2, Osteolysis, Monoclonal gammopathy of undetermined significance. Notable publications include 'Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma', 'Myeloma cell–derived Runx2 promotes myeloma progression in bone', and 'Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression'.